CNMD - コンメド (CONMED Corporation) コンメド

 CNMDのチャート


 CNMDの企業情報

symbol CNMD
会社名 Conmed Corp. (コンメド)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Electromedical_Electrotherapeutic Apparatus  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 コンメッド(CONMED Corporation)は医療技術会社である。同社は外科用機器および関連機器の開発、製造および販売に従事する。同社は低侵襲性治療用外科用器具を提供する。同社の製品は整形外科、一般外科、婦人科、脳神経外科、胃腸病学などの専門分野で外科医・医師に使用される。同社の製品ラインは整形外科手術、一般外科手術、手術視覚化を含む。同社の整形外科用製品ラインにはスポーツ医学、動力付き外科用器具、スポーツ用の生物製剤と組織が含まれる。同社の製品は「Hall」、「CONMED Linvatec」、「Concept」、「Shutt」を含むブランドで販売される。   コンメドは米国の手術器具や装置に特化した大手医療品メ―カ―。内視鏡などの腹腔鏡手術や、そのほかの整形外科市場向けの受電手術器具、心臓モニタリング及び血液酸素化モニタリング用ECG電極製品、手術用電動ノコギリ、ドリル、発電機などを提供する。本社はニューヨーク州ウティカ。   CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
本社所在地 525 French Road Utica NY 13502 USA
代表者氏名 Mark E. Tryniski マークE.トゥリニスキ
代表者役職名 Independent Chairman of the Board
電話番号 +1 315-624-3215
設立年月日 25600
市場名 NASDAQ National Market System
ipoyear 1987年
従業員数 3100人
url www.conmed.com
nasdaq_url https://www.nasdaq.com/symbol/cnmd
adr_tso
EBITDA EBITDA(百万ドル) 125.32100
終値(lastsale) 73.67
時価総額(marketcap) 2070919320.85
時価総額 時価総額(百万ドル) 259.956
売上高 売上高(百万ドル) 827.55600
企業価値(EV) 企業価値(EV)(百万ドル) 2485.742
当期純利益 当期純利益(百万ドル) 41.36900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 CONMED Corporation revenues increased 8% to $414.9M. Net income increased from $1.6M to $19.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Restructuring decrease from $19M (expense) to $0K Derivatives increase from $1.8M to $5.9M (income) Restructuring - COGS decrease from $1.5M (expense) to $0K.

 CNMDのテクニカル分析


 CNMDのニュース

   CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4  2020/01/31 08:37:00 Zacks Investment Research
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
   CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange  2020/01/29 21:03:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to begin trading on the NYSE effective at the open of markets on February 10, 2020. The Company’s shares will continue to trade on the NASDAQ until the transfer is completed and will continue to trade under the ticker “CNMD” as part of the transfer to the NYSE. “We are excited t
   CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/01/29 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margi
   CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020  2020/01/06 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2289828. This conference call will also be web
   CONMED Corporation to Present at the J.P. Morgan Healthcare Conference  2020/01/02 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA. A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conme
   CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4  2020/01/31 08:37:00 Zacks Investment Research
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
   CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange  2020/01/29 21:03:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to begin trading on the NYSE effective at the open of markets on February 10, 2020. The Company’s shares will continue to trade on the NASDAQ until the transfer is completed and will continue to trade under the ticker “CNMD” as part of the transfer to the NYSE. “We are excited t
   CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/01/29 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margi
   CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020  2020/01/06 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2289828. This conference call will also be web
   CONMED Corporation to Present at the J.P. Morgan Healthcare Conference  2020/01/02 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA. A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conme
   CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange  2020/01/29 21:03:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to begin trading on the NYSE effective at the open of markets on February 10, 2020. The Company’s shares will continue to trade on the NASDAQ until the transfer is completed and will continue to trade under the ticker “CNMD” as part of the transfer to the NYSE. “We are excited t
   CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/01/29 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margi
   CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020  2020/01/06 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2289828. This conference call will also be web
   CONMED Corporation to Present at the J.P. Morgan Healthcare Conference  2020/01/02 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA. A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conme
   Global Surgical Sutures and Staples Market Report 2020 with Profiles of Major Players - Ethicon Endo-Surgery, Stryker, Smith & Nephew, Conmed, Medtronic - ResearchAndMarkets.com  2019/12/12 11:08:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Surgical Sutures And Staples Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering. The global surgical sutures and staples market was valued at about $7.3 billion in 2018 and is expected to grow to $9.11 billion at a CAGR of 5.7% through 2022. The surgical sutures and staples market consists of sales of surgical sutures and staples and related services. Surgical sutures and staples are medical devices used by surgeons to hold skin,

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 コンメド CNMD CONMED Corporation)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)